Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators

老年癌症患者的尊严治疗:确定机制和调节因素

基本信息

  • 批准号:
    10298222
  • 负责人:
  • 金额:
    $ 34.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-10 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Nearly 600,000 older Americans die a cancer-related death each year. Maintaining human dignity is central to quality of life for patients with serious illness. Our long-term goal is to foster optimal humanistic modes of patient-centered clinical communication. We focus in the proposed study on Dignity Therapy (DT) which was designed to preserve cancer patients’ dignity despite declines in their health. Theoretically grounded in gerontological life review research, DT involves a therapist guiding a patient to generate their own unique, structured life narrative. Patients report benefits of DT but to date the mechanisms of DT have not been empirically investigated. As the use of this therapy spreads internationally, there is thus a pressing need to delineate precise mechanisms. The proposed study is the first to reliably analyze the content of older cancer patients’ interactions with the therapist in DT sessions (N=280 older adults who received DT). Our design allows for investigation of two mechanisms theoretically central to improving patient dignity through DT. These proposed mechanisms, empathic provider-patient communication during DT and richness of the patient’s life narrative produced during DT, will be used analytically as predictors of pre-to-post-therapy change in dignity impact. Our proposed study uses innovative methodological tools: it will employ both interactional and narrative analysis, grounded in the patient’s own experience, to establish mechanisms through which the therapy affects patient dignity. Past research has suffered due to assessment of conceptually distal outcomes of receiving DT. In response, the proposed outcomes have been chosen as proximal constructs closely guided by DT’s conceptual underpinnings. Our primary outcome of interest is the extent to which the patients sense of dignity increases from pre-to-posttest (i.e., Dignity Impact). Another aspect of the proposed study is to investigate when patients are most able to engage in DT. This will be accomplished through assessing whether extent of dignity impact after DT is moderated by patients’ symptom severity. Together, delineating mechanisms and identifying best timing for patient engagement in DT will provide substantial progress in implementing DT as a form of psychosocial care for older cancer patients. Our interdisciplinary team ensures that study findings will be implemented to improve DT training and delivery. This includes our innovative dissemination plan of hosting a Science of Care Summit with national opinion leaders. Our specific aims are as follows: SA1: Delineate the relation between empathic communication and higher patient dignity impact (primary outcome) pre-to-post- therapy. SA2: Investigate the relation between richness of the life narrative the patient is guided to produce during DT, and dignity impact (primary outcome) pre-to-post therapy.SA3: Identify the best-fitting model of relation of patient-provider empathic communication to post-therapy impact on patients’ dignity, with narrative richness as a mediator and patients’ symptom severity as a moderator (i.e., moderated-mediation analyses).
项目摘要 每年将近60万名美国人死亡与癌症有关的死亡。维持人的尊严是 患有严重疾病的患者的生活质量。我们的长期目标是培养最佳的人文主义模式 以患者为中心的临床交流。我们专注于拟议的关于尊严治疗(DT)的研究 旨在保护癌症患者的尊严使命的健康状况下降。理论上扎根 老年生命评论研究,DT涉及一名治疗师指导患者产生自己独特的, 结构化的生活叙事。患者报告了DT的好处,但迄今为止,DT的机制尚未 经验研究。随着这种疗法的使用在国际上传播,因此有必要 描述精确的机制。拟议的研究是第一个可靠地分析旧癌症含量的研究。 患者在DT课程中与治疗师的相互作用(n =接受DT的280名老年人)。我们的设计 允许对通过DT提高患者尊严提高患者尊严的两种机制进行投资。这些 拟议的机制,DT期间的移情提供者与医生交流以及患者一生的丰富性 在DT期间产生的叙述将在分析上用作尊严前进行验证变化的预测指标 影响。我们提出的研究使用创新的方法论工具:它将采用互动和叙事 分析以患者自身的经验为基础,以建立治疗影响的机制 患者尊严。过去的研究因评估接受DT的概念远端结果而受到影响。 作为回应,已选择拟议的结果作为由DT的密切指导的代理结构 概念上的基础。我们感兴趣的主要结果是患者的忠诚感的程度 从前到遗物的增加(即尊严影响)。拟议的研究的另一个方面是调查 当患者最能够参与DT时。这将通过评估是否范围 DT后的尊严影响由患者的症状严重程度缓解。一起描绘机制和 确定患者参与DT的最佳时机将在实施DT作为一个 癌症患者的社会心理护理形式。我们的跨学科团队确保学习发现将 实施以改善DT培训和交付。这包括我们托管的创新传播计划 与国家意见领袖的护理科学峰会。我们的具体目的如下:SA1:描述 移情沟通与较高的患者命运性影响(主要结果)之间的关系 治疗。 SA2:调查生活叙事的丰富性之间的关系。 在DT期间,尊严影响(主要结果)前至第一个疗法。SA3:确定最合适的模型 患者支持者的移情沟通与治疗后对患者尊严的影响的关系,叙述 作为调解人的丰富度和患者的症状严重程度作为主持人(即,调节分析)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

SUSAN BLUCK的其他基金

Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators
老年癌症患者的尊严治疗:确定机制和调节因素
  • 批准号:
    10487457
    10487457
  • 财政年份:
    2021
  • 资助金额:
    $ 34.2万
    $ 34.2万
  • 项目类别:

相似海外基金

The Meharry Cancer Summer Research Program (SuRP)
梅哈里癌症夏季研究计划 (SuRP)
  • 批准号:
    10715291
    10715291
  • 财政年份:
    2023
  • 资助金额:
    $ 34.2万
    $ 34.2万
  • 项目类别:
International Conference on Cancer Health Disparities
国际癌症健康差异会议
  • 批准号:
    10606212
    10606212
  • 财政年份:
    2023
  • 资助金额:
    $ 34.2万
    $ 34.2万
  • 项目类别:
Hospice exposure and utilization among older African Americans with ADRD and their decisional support persons
患有 ADRD 的老年非洲裔美国人及其决策支持人员的临终关怀暴露和利用
  • 批准号:
    10679558
    10679558
  • 财政年份:
    2023
  • 资助金额:
    $ 34.2万
    $ 34.2万
  • 项目类别:
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
  • 批准号:
    10797938
    10797938
  • 财政年份:
    2023
  • 资助金额:
    $ 34.2万
    $ 34.2万
  • 项目类别:
Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
  • 批准号:
    10818088
    10818088
  • 财政年份:
    2023
  • 资助金额:
    $ 34.2万
    $ 34.2万
  • 项目类别: